Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04062552 · ClinicalTrials.gov registry record · NA

Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers

A NA study of Advanced Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, sponsored by University of Rochester NCORP Research Base.

Active
Registry status
NA
Development phase
208
Enrollment target
20
Study locations

NCT04062552: Active NA study of Advanced Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, sponsored by University of Rochester NCORP Research Base.

NCT04062552 is a NA study of Advanced Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm that is active but no longer recruiting, run by University of Rochester NCORP Research Base. The registered enrollment target is 208 participants, above the 175-participant average among 108 other Advanced Malignant Solid Neoplasm trials with a reported enrollment target (19% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04062552, a NA study of Advanced Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, is active but no longer recruiting, sponsored by University of Rochester NCORP Research Base.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
208 participants
Enrollment target
20
Study locations

Study Summary

This trial studies the delivery of the ENABLE palliative care program by two different methods called a Virtual Learning Collaborative or Technical Assistance for patients with advanced cancer and their caregivers. Palliative care is specialized medical care for people with a serious illness that occurs at the same time as other medical treatment. The purpose of palliative care is to provide relief from symptoms and stress of serious illness, to help patients and their families clarify goals of care, and to focus on social support and spiritual well-being. The focus of the ENABLE palliative care program is on living well, managing stress, patient communication of their personal values and hopes for care, social support, and symptom management. This study may help doctors find the best ways to include palliative care services into their practices and the impact of palliative care on cancer patients and their caregivers' quality of life.

Primary Outcome

Defined as having a palliative care assessment and completing at least 4 ENABLE sessions. A logit generalized estimating equation model with exchangeable correlation structure (to account for clustering within practice) will be fitted to a binary patient uptake indicator ("yes" if the patient completed a palliative care assessment and at least 4 ENABLE program sessions and "no" if the patient does not), with the group assignment as the main predictor. Model-predicted uptake proportions, odds rat

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Educational Intervention
  • OTHER Behavioral, Psychological or Informational Intervention
  • PROCEDURE Medical Examination Assessment

Study Locations (20)

Hawaii

  • Island Urology-Hilo - Hilo
  • Hawaii Cancer Care Inc - Waterfront Plaza - Honolulu
  • Island Urology - Honolulu
  • Queen's Cancer Cenrer - POB I - Honolulu
  • Queen's Medical Center - Honolulu
  • Straub Clinic and Hospital - Honolulu
  • University of Hawaii Cancer Center - Honolulu
  • Hawaii Cancer Care Inc-Liliha - Honolulu
  • Kuakini Medical Center - Honolulu
  • Queen's Cancer Center - Kuakini - Honolulu
  • The Cancer Center of Hawaii-Liliha - Honolulu
  • Kapiolani Medical Center for Women and Children - Honolulu
  • Wilcox Memorial Hospital and Kauai Medical Clinic - Lihue
  • Hawaii Cancer Care - Westridge - ‘Aiea
  • Pali Momi Medical Center - ‘Aiea
  • Queen's Cancer Center - Pearlridge - ‘Aiea
  • The Cancer Center of Hawaii-Pali Momi - ‘Aiea

Arkansas

  • Mercy Hospital Fort Smith - Fort Smith

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Florida

  • Holy Cross Hospital - Fort Lauderdale

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2021-03-09
Est. Completion 2026-08-23
Phase NA

What the registry record for NCT04062552 still lists

NCT04062552 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, above the 175-participant average among 108 other Advanced Malignant Solid Neoplasm trials with a reported enrollment target (19% higher).

The record links to 3 conditions, with Advanced Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04062552 names 20 study sites across 4 states, led by Hawaii, Arkansas, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT04062552 about?

NCT04062552 is a clinical study titled "Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers". This trial studies the delivery of the ENABLE palliative care program by two different methods called a Virtual Learning Collaborative or Technical Assistance for patients with advanced cancer and their caregivers. Palliative care is specialized medical care for people with a serious illness that oc...

What is the current status of trial NCT04062552?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2021-03-09. Estimated completion is 2026-08-23.

What conditions does trial NCT04062552 study?

This clinical trial studies the following conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm.

What interventions are being tested in trial NCT04062552?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Educational Intervention (OTHER), Behavioral, Psychological or Informational Intervention (OTHER), Medical Examination Assessment (PROCEDURE).

Who is sponsoring clinical trial NCT04062552?

This trial is sponsored by University of Rochester NCORP Research Base, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04062552 being conducted?

This trial has 20 study locations across Arkansas, District of Columbia, Florida, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04062552's enrollment target sits among peer trials

208 9th of 108 higher than 99 of 108 other Advanced Malignant Solid Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advanced Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465774 · 208 participants

    Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

  • NCT03803332 · 208 participants · NA

    A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

  • NCT04732065 · 208 participants · Phase 1

    ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

  • NCT05293756 · 208 participants · NA

    OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04062552, the US trial registry maintained by the National Library of Medicine. NCT04062552 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.